Loading company…
San Diego drug developer focused on treatments for neurological disorders, including Alzheimer's, multiple sclerosis and Parkinson's.
Neurana Pharmaceuticals develops pharmaceutical treatments for neurological disorders, targeting conditions such as Alzheimer's disease, multiple sclerosis and Parkinson's disease. Founded in 2013 and headquartered in San Diego, US, it is led by CEO Craig Thompson. In May 2018 it closed a USD 60 mn Series A led by Sofinnova Investments, with H.I.G. BioHealth Partners, Longitude Capital, MagnaSci Ventures and New Leaf Venture Partners participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in